Hudson Bay Capital Management LP Catalyst Pharmaceuticals, Inc. Transaction History

Hudson Bay Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$13.18 - $17.11 $1.58 Million - $2.05 Million	120,000 Added 75.0%	280,000 $4.46 Million
Q4 2023 Feb 14, 2024	SELL	$11.78 - $17.29 $1.65 Million - $2.42 Million	-140,000 Reduced 46.67%	160,000 $2.69 Million
Q3 2023 Nov 14, 2023	BUY	$11.69 - $15.02 $1.17 Million - $1.5 Million	100,000 Added 50.0%	300,000 $3.51 Million
Q2 2023 Aug 14, 2023	BUY	$11.5 - $18.08 $2.3 Million - $3.62 Million	200,000 New	200,000 $2.69 Million

326

94.6M

19.1K

51.1K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.12B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Hudson Bay Capital Management LP with notifications on news.